Given the role of IL-36γ in the activation of the MEK/ERK and JNK/c-Jun cascades, we further hypothesized that IL-36γ triggers the MAP signaling cascade in breast cancer MCF7 cells. Here, MAP2K7 is linked to breast carcinoma.